Oregon leads in affordable medical cannabis

30/10/2023
Flag of USA, Cannabis, Oregon

Medical cannabis affordability: A state-by-state analysis

In an illuminating analysis by Leafwell, which scrutinised over 130,000 medical cannabis products across dispensaries nationwide, Oregon has emerged as the state with the most affordable medical marijuana, averaging $6.91 per gram.

This contrasts starkly with New York, where the limited operational dispensaries charge an average of $23.17 per gram, making it the least affordable in the United States.

The price spectrum of medical cannabis across the US

The study indicates that the average price for medical cannabis flower stands at $13.90 per gram, with states like Maine, Colorado, Arkansas, Michigan, Ohio, Mississippi, California, New Mexico, and Arizona also offering lower-than-average prices.

The wide price range reflects the diverse regulatory environments and market dynamics at play in the medical cannabis industry.

Factors influencing cannabis pricing

Several factors contribute to the pricing disparities observed across states. Regulatory frameworks, the number of licensed dispensaries, production costs, and state taxes all play a role in determining the final retail price of medical cannabis.

In New York, criticism has been levelled at regulators for not licensing enough cannabis retailers to meet consumer demand, a situation that may contribute to higher prices.

Understanding state regulations and consumer impact

With thirty-eight states regulating the production and sale of medical cannabis products, the landscape of cannabis affordability is complex. The Leafwell report underscores the need for a closer examination of how state policies impact consumer access and affordability of medical cannabis.

Implications for medical cannabis users

The financial accessibility of medical cannabis is a critical issue for patients who rely on it for therapeutic purposes. The disparity in pricing can significantly affect the quality of life for patients, especially those in states with higher costs, who may find it challenging to maintain consistent access to their medication.

Comparative analysis: Oregon vs. New York

Oregon's position as the most affordable state for medical cannabis is not new. Historical data from sources like KDRV highlight Oregon's longstanding reputation for lower cannabis prices. Conversely, New York's high pricing is a continuing challenge, with the state's restrictive licensing contributing to limited availability and higher costs.

Looking at the broader picture

The Leafwell analysis is a snapshot of the current state of medical cannabis affordability in the US. It provides valuable insights for policymakers, healthcare providers, and consumers alike, emphasising the need for a balanced approach to cannabis regulation that prioritises patient access and affordability.

For more detailed information on Oregon's medical marijuana pricing, readers can refer to the KDRV report.

    Back to blog
    USA

    Leave a comment

    Please note, comments need to be approved before they are published.

    Robin Roy Krigslund-Hansen

    Robin Roy Krigslund-Hansen

    About the author:

    Robin Roy Krigslund-Hansen is known for his extensive knowledge and expertise in the fields of CBD and hemp production. With a career spanning over a decade in the cannabis industry, he has dedicated his life to understanding the intricacies of these plants and their potential benefits to human health and the environment. Over the years, Robin has worked tirelessly to promote the full legalization of hemp in Europe. His fascination with the plant's versatility and potential for sustainable production led him to pursue a career in the field.

    More about Robin Roy Krigslund-Hansen

    Related products

    1 of 3